Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 187 Records) |
| Query Trace: Neoplasms and CYP3A5[original query] |
|---|
| Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis. Frontiers in cardiovascular medicine 2021 8 651269. Yang Xinyu, Li Guoping, Guan Manke, Bapat Aneesh, Dai Qianqian, Zhong Changming, Yang Tao, Luo Changyong, An Na, Liu Wenjing, Yang Fan, Pan Haie, Wang Pengqian, Gao Yonghong, Gong Ye, Das Saumya, Shang Hongcai, Xing Yanw |
| Relevance of CYP3A5 Expression on the Clinical Outcome of Patients With Renal Cell Carcinoma. Anticancer research 2021 5 41 (5): 2511-2521. Matsumoto Jun, Kotera Yumi, Watari Shogo, Takeuchi Koichi, Ueki Hideo, Koyama Toshihiro, Wada Koichiro, Fujiyoshi Masachika, Nasu Yasutomo, Ariyoshi Norita |
| CYP3A gene variability and cancer cells response to the treatment. General physiology and biophysics 2021 3 40 (1): 49-59. Šemeláková Martina, Malini?ová Lenka, Macejová Mária, Pristaš Pet |
| Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients. Frontiers in pharmacology 2021 12 12 661443. Miranda Carla, Galleguillos Macarena, Torres Roberto, Tardón Karla, Cáceres Dante D, Lee Kuen, Redal María A, Varela Nelson M, Quiñones Luis |
| Effects of CYP3A4/5 and ABC transporter polymorphisms on osimertinib plasma concentrations in Japanese patients with non-small cell lung cancer. Investigational new drugs 2022 9 40 (6): 1254-1262. Yokota Hayato, Sato Kazuhiro, Sakamoto Sho, Okuda Yuji, Fukuda Natsuki, Asano Mariko, Takeda Masahide, Nakayama Katsutoshi, Miura Masato |
| An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer. Frontiers in pharmacology 2022 8 13 897951. Roncato Rossana, Gerratana Lorenzo, Palmero Lorenza, Gagno Sara, Poetto Ariana Soledad, Peruzzi Elena, Zanchetta Martina, Posocco Bianca, De Mattia Elena, Canil Giovanni, Alberti Martina, Orleni Marco, Toffoli Giuseppe, Puglisi Fabio, Cecchin Eri |
| Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicities. Anti-cancer drugs 2022 Aug . Kwok Wang Chun, Lam David Chi Leung, Ip Mary Sau Man, Tam Terence Chi Chun, Ho James Chung M |
| Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers in pharmacology 2022 13 918219. Tan Tingfei, Han Gongwei, Cheng Ziwei, Jiang Jiemei, Zhang Li, Xia Zitong, Wang Xinmeng, Xia Qu |
| Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis. Cancers 2022 2 14 (3): . Uittenboogaard Aniek, Neutel Céline L G, Ket Johannes C F, Njuguna Festus, Huitema Alwin D R, Kaspers Gertjan J L, van de Velde Mirjam |
| Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study. BMC pulmonary medicine 2022 11 22 (1): 454. Nio Yuta, Ishida Hiroo, Matsumoto Natsumi, Kusumoto Sojiro, Kubota Yutaro, Tsunoda Takuya, Sasaki Yasutsuna, Fujita Ken-Ic |
| Impacts of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of apixaban in patients with non-valvular atrial fibrillation. European journal of clinical pharmacology 2022 11 79 (1): 127-135. Nakagawa Junichi, Kinjo Takahiko, Aiuchi Naoya, Ueno Kayo, Tomita Hirofumi, Niioka Takeno |
| Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant. European journal of clinical pharmacology 2022 1 78 (4): 613-621. Hibino Hideyuki, Sakiyama Naomi, Makino Yoshinori, Makihara-Ando Reiko, Horinouchi Hidehito, Fujiwara Yutaka, Kanda Shintaro, Goto Yasushi, Yoshida Tatsuya, Okuma Yusuke, Shinno Yuki, Murakami Shuji, Hashimoto Hironobu, Akiyoshi Takeshi, Imaoka Ayuko, Ohe Yuichiro, Yamaguchi Masakazu, Ohtani Hisaka |
| Study on individualized analgesia guided by CYP3A4/5 polymorphisms in perioperative thoracoscopic surgery. American journal of translational research 2022 1 13 (12): 14211-14219. Wang Shengyan, Yao Yibing, Kong Min, Zhou Xuyan, Shen |
| Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 9 167 115479. Elena Peruzzi, Lorenzo Gerratana, Marcella Montico, Bianca Posocco, Serena Corsetti, Michele Bartoletti, Sara Gagno, Marco Orleni, Elena De Mattia, Massimo Baraldo, Erika Cecchin, Fabio Puglisi, Giuseppe Toffoli, Rossana Ronca |
| ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban. Drug design, development and therapy 2023 8 17 2513-2522. Hamin Kim, Tae-Jin Song, Jeong Yee, Dong-Hyeok Kim, Junbeom Park, Hye Sun Gw |
| Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing. Drug metabolism and personalized therapy 2023 7 . Ekaterina Olegovna Golubenko, Marina Ivanovna Savelyeva, Zhannet Alimovna Sozaeva, Vera Vyacheslavovna Korennaya, Irina Vladimirovna Poddubnaya, Timur Tejmurazovich Valiev, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ily |
| Is OPRM1 genotype a valuable predictor of VAS in patients undergoing laparoscopic radical resection of colorectal cancer with fentanyl? BMC anesthesiology 2023 5 23 (1): 173. Yan Zhou, Lei Cao, Yihui Yang, Yaoyi Gao, Yihao Li, Beili Wang, Baishen Pan, Jian Huang, Wei G |
| Cytochrome P450 oxidoreductase, POR, associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 5 . Fei Shen, Guanglong Jiang, Santosh Philips, Laura Gardner, Gloria Xue, Erica Cantor, Reynold C Ly, Wilberforce Osei, Xi Wu, Chau Dang, Donald Northfelt, Todd Skaar, Kathy D Miller, George W Sledge, Bryan P Schneid |
| Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 2023 3 24 (6): . Cantara Silvia, Dalmiglio Cristina, Marzocchi Carlotta, Sagnella Alfonso, Brilli Lucia, Trimarchi Andrea, Maino Fabio, Valerio Laura, Castagna Maria Graz |
| Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study. JCO precision oncology 2023 3 7 e2200580. Larkin Trisha, Kashif Reema, Elsayed Abdelrahman H, Greer Beate, Mangrola Karna, Raffiee Roya, Nguyen Nam, Shastri Vivek, Horn Biljana, Lamba Jatinder |
| Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
| Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study. BMC pharmacology & toxicology 2023 11 24 (1): 64. Jing Yang, Ying-Zi Sun, Qun-Fang Li, Zheng Fu, Yu-Yao Guan, Chao Song, Lei Zhe |
| Is higher docetaxel clearance in prostate cancer patients explained by higher CYP3A: An in vivo phenotyping study with midazolam. Journal of clinical pharmacology 2023 10 . Lisa T van der Heijden, Claire A Ribbers, M A C Vermunt, D Pluim, M Acda, M Tibben, H Rosing, J A J Douma, K Naipal, A M Bergman, J H Beijnen, A D R Huitema, F L Opd |
| Genetic Association in CYP3A4 and CYP3A5 genes elevate the risk of Prostate Cancer. Annals of human biology 2023 1 1-19. Bellah Sm Faysal, Salam Md Abdus, Billah S M Saker, Karim Md Reza |
| Population pharmacokinetics and pharmacogenetics of apatinib in adult cancer patients. British journal of clinical pharmacology 2023 1 . Yang Xin-Mei, Ye Pan-Pan, Liu Xiao-Lin, Guo Zi-Xuan, Kan Min, Li Qian, Song Lin-Lin, Liu Hong-Ying, Chen Ke-Guang, Shi Jin-Yi, Zhang Ye-Hui, Li Ya, Zhao Fu-Rong, van den Anker John, Li Yan, Zhao W |
| Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study. Research square 2024 8 . Sandra Swain, Ilana Schlam, D Max Smith, Cody Peer, Tristan Sissung, Keith Schmidt, Ming Tan, Ami Chitalia, Nanette Bishopric, Seth Steinberg, Hyoyoung Choo-Wosoba, Giulia Napoli, Christopher Gallagher, Nadia Ashai, Kristen Whitaker, Candace Mainor, Shruti Tiwari, Nicole Swanson, Stacy Malloy, Claudine Isaacs, William Fi |
| Potential association of SULT2A1 and ABCG2 variant alleles with increased risk for palbociclib toxicity. Pharmacogenomics 2024 8 1-9. Chong Wang, Mary Hwang, Brandon Paulson, Doreen Mhandire, Sadat Ozair, Tracey L O'Connor, Shipra Gandhi, Kristopher M Attwood, Daniel L Hertz, Andrew Kl Go |
| Correlation of Genetic Polymorphism of CYP3A5 to Cyclophosphamide Efficacy and Toxicity in Rhabdomyosarcoma Pediatric Egyptian Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2024 7 25 (7): 2445-2455. Cherine E ElShereef, Hala F Zaki, Osama A Badary, Sherif Kamal, Mohamed Nagy, Dalia Makhlouf, Mohamed Kamal, Inas Elnadi, Sameh A Abdelshafi, Sherif Abou El Naga, Mona M Sab |
| Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients. Asian Pacific journal of cancer prevention : APJCP 2024 4 25 (4): 1391-1409. Norhan Shalaby, Hala F Zaki, Osama A Badary, Sherif Kamal, Mohamed Nagy, Dalia Makhlouf, Amr Elnashar, Enas Elnadi, Sameh A Abdelshafi, Sherif Abouelnaga, Mona M Sab |
| Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics. Fundamental & clinical pharmacology 2024 1 . Emi Nakatsugawa, Takafumi Naito, Kaito Shibata, Ryo Kitajima, Junichi Kawaka |
- Page last reviewed:Feb 1, 2024
- Content source: